Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid Slade

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Current Genetic Medicine Reports|March 3, 2020
Evaluating the Integration of Genomics into Cancer Screening Programmes: Challenges and OpportunitiesSarah Briggs, Ingrid Slade
European Journal of Human Genetics : EJHG|May 15, 2026
From clinical genetics to genomic-based public health screening programmes: duty-based ethics as a guide for responsible implementationHelena Carley, Ingrid Slade
Clinical Medicine (London, England)|August 3, 2016
Genomics education for medical professionals - the current UK landscapeIngrid Slade, Deepak N Subramanian, Hilary Burton
European Journal of Human Genetics : EJHG|September 20, 2019
Rethinking the ethical principles of genomic medicine servicesStephanie B Johnson, Ingrid Slade, Alberto Giubilini, et al.
Genome Medicine|February 28, 2015
Development of cancer genetic services in the UK: A national consultationIngrid Slade, Daniel Riddell, Clare Turnbull, et al.
Cost Effectiveness and Resource Allocation : C/E|October 2, 2019
Understanding and using patient experiences as evidence in healthcare priority settingLeah Rand, Michael Dunn, Ingrid Slade, et al.
Journal of Community Genetics|February 29, 2016
A cost analysis of a cancer genetic service model in the UKIngrid Slade, Helen Hanson, Angela George, et al.
Drug Safety|December 17, 2009
Diagnostic utility of two case definitions for anaphylaxis: a comparison using a retrospective case notes analysis in the UKMichel Erlewyn-Lajeunesse, Sandra Dymond, Ingrid Slade, et al.
Familial Cancer|December 29, 2010
Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastomaIngrid Slade, Anne Murray, Sandra Hanks, et al.
Scientific Reports|July 14, 2016
Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patientsAngela George, Daniel Riddell, Sheila Seal, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Genetic Medicine Reports|March 3, 2020
Evaluating the Integration of Genomics into Cancer Screening Programmes: Challenges and OpportunitiesSarah Briggs, Ingrid Slade
European Journal of Human Genetics : EJHG|May 15, 2026
From clinical genetics to genomic-based public health screening programmes: duty-based ethics as a guide for responsible implementationHelena Carley, Ingrid Slade
Clinical Medicine (London, England)|August 3, 2016
Genomics education for medical professionals - the current UK landscapeIngrid Slade, Deepak N Subramanian, Hilary Burton
European Journal of Human Genetics : EJHG|September 20, 2019
Rethinking the ethical principles of genomic medicine servicesStephanie B Johnson, Ingrid Slade, Alberto Giubilini, et al.
Genome Medicine|February 28, 2015
Development of cancer genetic services in the UK: A national consultationIngrid Slade, Daniel Riddell, Clare Turnbull, et al.
Cost Effectiveness and Resource Allocation : C/E|October 2, 2019
Understanding and using patient experiences as evidence in healthcare priority settingLeah Rand, Michael Dunn, Ingrid Slade, et al.
Journal of Community Genetics|February 29, 2016
A cost analysis of a cancer genetic service model in the UKIngrid Slade, Helen Hanson, Angela George, et al.
Drug Safety|December 17, 2009
Diagnostic utility of two case definitions for anaphylaxis: a comparison using a retrospective case notes analysis in the UKMichel Erlewyn-Lajeunesse, Sandra Dymond, Ingrid Slade, et al.
Familial Cancer|December 29, 2010
Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastomaIngrid Slade, Anne Murray, Sandra Hanks, et al.
Scientific Reports|July 14, 2016
Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patientsAngela George, Daniel Riddell, Sheila Seal, et al.
Pageof 2